Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q4 2025 Earnings

13NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-1.19

-0.86

-0.54

-0.21

Details

Expected EPS

-0.458333

Actual EPS

-0.21

Surprise EPS

0.25

Surprise Percent

+54.18%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.21 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.